Alzheimer's Disease Revealed By Reliable Digital Memory Assessments Alzheimer's disease (AD) research has advanced in detecting pathological changes through biomarkers, but cognitive measures lag in capturing early, subtle impairments. Traditional assessments designed for overt deficits are now outpaced by discoveries in episodic memory networks within the medial temporal lobe, which are
Tag: Alzheimer’s disease (AD)
Dementia Risk Increase In Diabetic Patients With Poor Glycemic Control
Dementia Risk Increase In Diabetic Patients With Poor Glycemic Control Overview This study investigated the association between glycemic variability and dementia risk among 171,964 individuals with type 2 diabetes. Despite optimal glycosylated hemoglobin A1c (HbA1c) levels, variability in HbA1c over the long term was found to increase the hazard of dementia. The
Constructive Uses For Biomarker Testing In Dementia
Constructive Uses For Biomarker Testing In Dementia Overview The Investigating the Impact of Alzheimer’s Disease Diagnostics in British Columbia (IMPACT-AD BC) study aimed to evaluate the effects of Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker testing on medical decision-making, personal decision-making, and health system economics. This observational, longitudinal cohort study enrolled 149
Anticholinergic Medications And Cognitive Outcomes In Autistic Adults
Anticholinergic Medications And Cognitive Outcomes In Autistic Adults Overview This study investigates the impact of anticholinergic (AC) medications on cognitive outcomes in autistic adults, an area that has not been extensively researched. AC medications, known for their potential to cause cognitive impairment, are commonly used for various medical and psychiatric conditions. In
